Rice Hall James & Associates’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.17M | Sell |
|
|||||
|
2025
Q2 | $3.94M | Buy |
|
|||||
|
2025
Q1 | $2.83M | Sell |
|
|||||
|
2024
Q4 | $2.81M | Sell |
|
|||||
|
2024
Q3 | $3.45M | Buy |
|
|||||
|
2024
Q2 | $1.22M | Buy |
|
|||||
|
2024
Q1 | $1.06M | Buy |
|
|||||
|
2023
Q4 | $1.05M | Sell |
|
|||||
|
2023
Q3 | $1.05M | Sell |
|
|||||
|
2023
Q2 | $788K | Buy |
|
|||||
|
2023
Q1 | $676K | Buy |
|
|||||
|
2022
Q4 | $647K | Sell |
|
|||||
|
2022
Q3 | $619K | Sell |
|
|||||
|
2022
Q2 | $905K | Buy |
|
|||||
|
2022
Q1 | $941K | Buy |
|
|||||
|
2021
Q4 | $964K | Sell |
|
|||||
|
2021
Q3 | $2.51M | Sell |
|
|||||
|
2021
Q2 | $3.69M | Sell |
|
|||||
|
2021
Q1 | $5.59M | Buy |
|
|||||
|
2020
Q4 | $1.84M | Buy |
|